A Twist1-regulated distal enhancer crucial for Alx1 gene expression and function during craniofacial development

Area of Science:

• Genetics
• Developmental Biology
• Craniofacial Development

Background:

• ALX1 disruption causes frontonasal dysplasia syndrome-3, with severe craniofacial abnormalities.
• ALX1 plays critical roles in cranial mesoderm and neural crest-derived facial mesenchyme patterning.
• Molecular mechanisms regulating Alx1 gene expression in craniofacial development are poorly understood.

Purpose of the Study:

• To identify and functionally characterize regulatory elements controlling Alx1 gene expression during craniofacial development.
• To investigate the role of a novel distal enhancer, Alx1-DE1, in craniofacial patterning.
• To elucidate the involvement of transcription factors, such as Twist1, in regulating Alx1 expression.

Main Methods:

• Identification of a distal enhancer (Alx1-DE1) within the Lrriq1 gene intron.
• Deletion analysis of Alx1-DE1 to assess its impact on Alx1 expression and craniofacial development.
• Functional analysis of evolutionary conserved regions (ECR1-ECR4) within Alx1-DE1.
• ChIP assays to detect transcription factor binding (Twist1).
• Transgenic mouse models to study reporter gene expression driven by Alx1-DE1.

Main Results:

• Deletion of Alx1-DE1 specifically impaired Alx1 expression in frontonasal mesenchyme, causing craniofacial and ocular defects.
• ECR1 within Alx1-DE1 showed significant Twist1 transcription factor occupancy in embryonic frontonasal tissues.
• ECR1 drove Twist1-dependent reporter gene expression in the developing periocular and frontonasal mesenchyme in transgenic mice.
• A human genetic variation near ECR1 is associated with facial and cranial vault shape differences.

Conclusions:

• Alx1-DE1 is a critical tissue-specific enhancer regulating Alx1 expression during craniofacial development.
• Twist1 and other regulators control craniofacial patterning and morphogenesis through enhancers like Alx1-DE1.
• This study provides insights into the molecular basis of frontonasal dysplasia and related craniofacial disorders.